What Does Passage Bio Do?

Total employees83
HeadquartersPhiladelphia
Founded2017

Passage Bio (NASDAQ: PASG) is a clinical-stage genetic medicines company on a mission to develop and commercialize transformative therapies for patients suffering from devastating rare monogenic central nervous system (CNS) disorders. The company leverages a strategic collaboration and licensing agreement with the University of Pennsylvania's Gene Therapy Program (GTP), a leader in gene therapy research and development, to access a broad portfolio of AAV-delivered gene therapies and cutting-edge vector engineering and manufacturing capabilities. Their pipeline focuses on conditions with significant unmet medical needs, including GM1 gangliosidosis, Krabbe disease, and frontotemporal dementia (FTD).

Where Is Passage Bio's Headquarters?

HQ Function

Serves as the primary corporate office, housing executive leadership, clinical development, regulatory affairs, research and development oversight, and administrative functions.

Notable Features:

Located in a prominent commercial skyscraper in Center City Philadelphia, offering modern office facilities and convenient access to the city's biotech ecosystem.

Work Culture:

Likely a dynamic, science-driven, and collaborative environment, focused on innovation and achieving milestones in the development of life-changing therapies for rare diseases. Emphasis on patient-centricity and scientific rigor.

HQ Significance:

The Philadelphia location is strategic, placing Passage Bio within a vibrant hub for life sciences and in close proximity to key academic partners like the University of Pennsylvania. This facilitates collaboration and talent acquisition.

Values Reflected in HQ: The choice of a well-regarded, central location reflects professionalism, ambition, and a commitment to being part of a leading biomedical community.

Location:

Passage Bio's primary operations are centered in the United States. Their global reach is mainly through clinical trial sites, which may be located in various countries to ensure diverse patient enrollment for their rare disease programs. They also engage with the international scientific and medical community for research collaborations and to stay at the forefront of gene therapy advancements.

Street Address:

One Commerce Square, 2005 Market Street, Suite 1050

City:

Philadelphia

State/Province:

PA

Country:

USA

Where Else Does Passage Bio Operate Around the World?

No additional office locations available.

Buying Intent Signals for Passage Bio

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Passage Bio? Meet the Executive Team

As of April 2025, Passage Bio' leadership includes:

William Chou, M.D. - President and Chief Executive Officer
Simona King - Chief Financial Officer
Mark Forman, M.D., Ph.D. - Chief Medical Officer
Alex Fotopoulos - Chief Technical Officer
Robin Soffer - General Counsel & Corporate Secretary

Who's Investing in Passage Bio?

Passage Bio has been backed by several prominent investors over the years, including:

OrbiMed
Frazier Healthcare Partners
Versant Ventures
Access Biotechnology
Lily Asia Ventures
New Leaf Venture Partners
Vivo Capital
Logos Capital

What Leadership Changes Has Passage Bio Seen Recently?

Hire3
Exits2

Passage Bio has seen significant leadership renewal in the past year, with new appointments to key C-suite positions including CEO, CFO, and CMO, to guide its clinical and strategic objectives.

Departures

Bruce Goldsmith, Ph.D., Bruce Goldsmith, Ph.D., stepped down as President and CEO, with William Chou, M.D. appointed as successor.
Kathleen Borthwick, Kathleen Borthwick departed as Chief Financial Officer, with Simona King appointed as successor.

New Appointments:

William Chou, M.D., William Chou, M.D., appointed as President and Chief Executive Officer.
Simona King, Simona King appointed as Chief Financial Officer.
Mark Forman, M.D., Ph.D., Mark Forman, M.D., Ph.D., appointed as Chief Medical Officer.

What Technology (Tech Stack) Is Used byPassage Bio?

Discover the tools Passage Bio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Passage Bio Email Formats and Examples

Passage Bio likely uses common corporate email formats. The most prevalent patterns for companies of this nature are [first_initial][last]@passagebio.com or [first].[last]@passagebio.com. For example, Jane Doe might be jdoe@passagebio.com or jane.doe@passagebio.com.

[first_initial][last]@passagebio.com

Format

wchoi@passagebio.com

Example

70%

Success rate

What's the Latest News About Passage Bio?

GlobeNewswire • January 9, 2024

Passage Bio Appoints Simona King as Chief Financial Officer and Mark Forman, M.D., Ph.D., as Chief Medical Officer

Passage Bio announced the appointments of Simona King as Chief Financial Officer and Mark Forman, M.D., Ph.D., as Chief Medical Officer. These appointments aim to strengthen the company's leadership team as it advances its pipeline of genetic medicines for CNS disorders....more

GlobeNewswire • August 1, 2023

Passage Bio Appoints William Chou, M.D., as President and Chief Executive Officer

Passage Bio announced the appointment of William Chou, M.D., as its new President and Chief Executive Officer, and a member of the Board of Directors. Dr. Chou brings extensive experience in clinical development, particularly in rare diseases and gene therapy....more

GlobeNewswire • May 8, 2024

Passage Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

Passage Bio provided an update on its clinical programs, including its lead program for GM1 gangliosidosis, and reported financial results for the first quarter of 2024. The company highlighted progress in trial enrollment and outlined upcoming milestones....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Passage Bio, are just a search away.